Stemline is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer.
Business Model:
Revenue: $47M
Employees: 51-200
Address: 750 Lexington Ave.
City: New York
State: NY
Zip: 10022
Country: US
Stemline is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer.
Contact Phone:
+16465022310
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
1/29/2013
Ticker Symbol:
STML
IPO Price:
$10/share
Amount Raised:
$33M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2010 | Venture Round | $600k | 1/2019 | Post-IPO Equity | $92M | 1/2013 | IPO | $33.2M |
|
3/2010 | Venture Round | $1.3M | 1/2012 | Debt Financing | $740k | 4/2008 | Series A | 1 | $12.5M |
Pequot Capital Pequot Capital Pequot Capital Pequot Capital |
12/2012 | Debt | $740k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|